Our Biopharm^® Platform of software shapes the next generation bioprocessing of modalities including monoclonal antibodies, vaccines, viral vectors, and antibody-drug conjugates.

From techno-economic assessments to sustainability insights, and from machine learning-driven analytics to visualization tools, our suite of BioSolve^® applications has been the platform of choice to evolve and transform bioproduction for almost two decades.